COVID-19 Respiratory Infection, Influenza Viral Infections, Respiratory Syncytial Virus Infections, Rhinoviral Infections
Conditions
Keywords
Wearable Device, Smart Watch
Brief summary
This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respiratory Syncytial Virus. This study aims to develop a forecasting model to predict infection onset prior to symptom onset using wearable device data and known symptom onset and test dates.
Detailed description
DUHS patients who have diagnostic testing for Influenza, COVID-19, Respiratory syncytial virus, and Rhinovirus testing within the past 5 years will be initially screened for an email address. Participants will learn about this study via email with a link to complete the survey. A Study ID will be generated for all individuals with an email. Participants will be asked to complete an e-consent via a REDCap survey. If participants have questions, they are provided with study contact information via e-mail. Participants will complete the survey which will have questions on prior symptoms and device ownership (anticipated time to complete: 5 minutes). If the participant owns one of the following wearable devices (Fitbit, Garmin, or Apple Watch), they will be sent to a redirect URL to login into their device account (for Fitbit or Garmin) or be provided with instructions to export their Healthkit data and dump their data into a unique Strongbox link (for Apple Watch). If participants choose to contribute their wearable device data to the study and the data obtained pass through data quality thresholds, they will receive compensation. There is no compensation for survey completion. The investigators will ask participants if they wish to be re-contacted for future studies related to this project. The investigators will collect endpoint data values from the wearable. These data will be used to estimate daily activity amounts and intensity (i.e., exercise and walking), standing, sleep amounts, sleep quality, heart rate variability, SpO2, respiratory rate, and heart rate. All of the wearable device data will be identified using a Study ID. The investigators will use statistical and machine learning models to develop personalized baseline models of health and detect anomalies that can help in identifying COVID-19 infection. The investigators will validate and test the sensitivity and specificity of our mode for detecting respiratory infection vs. no infection against symptom surveys and diagnostic testing as ground truth. The model testing and validation will be done separately for each brand of device and will be further modified according to the type of respiratory infection.
Interventions
None listed
Sponsors
Biomedical Advanced Research and Development Authority
Duke University
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* 18 years of age and older
Exclusion criteria
* Less than 18 years of age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Develop a forecasting model to predict infection onset prior to symptom onset using the amount of time between known symptom onset and test dates | 18 Months | Known symptom onset and test dates will serve to validate the model |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of missingness in the wearable device data | 18 Months | Used to determine the performance of the forecasting model. |
| Determine the performance of the forecasting model on a new viral strain through transfer learning | 18 Months | — |
| Determine if there are signal differences that can differentiate the type of respiratory infection (e.g., COVID-19 vs. Influenza) | 18 Months | — |
| Determine if there are physiological differences between varying respiratory infections over time | 18 Months | — |
| Determine the performance of the forecasting model based on the severity of symptoms | 18 Months | — |
| Determine if there are physiological differences between initial infection and reinfection | 18 Months | — |
Countries
United States
Outcome results
None listed